A new scheme to discover functional associations and regulatory networks of E3 ubiquitin ligases by unknown
PROCEEDINGS Open Access
A new scheme to discover functional
associations and regulatory networks of E3
ubiquitin ligases
Kai-Yao Huang1, Julia Tzu-Ya Weng1,2, Tzong-Yi Lee1,2* and Shun-Long Weng3,4,5*
From The Fourteenth Asia Pacific Bioinformatics Conference (APBC 2016)
San Francisco, CA, USA. 11 - 13 January 2016
Abstract
Background: Protein ubiquitination catalyzed by E3 ubiquitin ligases play important modulatory roles in various
biological processes. With the emergence of high-throughput mass spectrometry technology, the proteomics
research community embraced the development of numerous experimental methods for the determination of
ubiquitination sites. The result is an accumulation of ubiquitinome data, coupled with a lack of available resources
for investigating the regulatory networks among E3 ligases and ubiquitinated proteins. In this study, by integrating
existing ubiquitinome data, experimentally validated E3 ligases and established protein-protein interactions, we
have devised a strategy to construct a comprehensive map of protein ubiquitination networks.
Results: In total, 41,392 experimentally verified ubiquitination sites from 12,786 ubiquitinated proteins of humans
have been obtained for this study. Additional 494 E3 ligases along with 1220 functional annotations and 28588
protein domains were manually curated. To characterize the regulatory networks among E3 ligases and ubiquitinated
proteins, a well-established network viewer was utilized for the exploration of ubiquitination networks from 40892
protein-protein interactions. The effectiveness of the proposed approach was demonstrated in a case study examining
E3 ligases involved in the ubiquitination of tumor suppressor p53. In addition to Mdm2, a known regulator of p53, the
investigation also revealed other potential E3 ligases that may participate in the ubiquitination of p53.
Conclusion: Aside from the ability to facilitate comprehensive investigations of protein ubiquitination networks, by
integrating information regarding protein-protein interactions and substrate specificities, the proposed method could
discover potential E3 ligases for ubiquitinated proteins. Our strategy presents an efficient means for the preliminary
screen of ubiquitination networks and overcomes the challenge as a result of limited knowledge about E3
ligase-regulated ubiquitination.
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Introduction
Protein ubiquitination involves a series of enzymatic
reactions such as E1 activation, E2 conjugation, and E3
ligation, resulting in the conjugation of single or multiple
ubiquitin proteins at a target lysine residue [1]. Numerous
substrate proteins with ubiquitination sites have been
characterized to date, owing to the emergence of
high-throughput mass spectrometry-based proteomics
approaches [2–4]. Identified to play key roles in tran-
scriptional regulation, signal transduction, develop-
ment, apoptosis, endocytosis, cell proliferation and
cancers, ubiquitination of the lysine residue has been
regarded as an essential mediator of various biological
processes [5–7]. Among the enzymes that catalyze
protein ubiquitination, E3 ligases are particularly im-
portant for the recognition of substrate sites to facili-
tate ubiquitin-mediated protein degradation [8]. The
relationships between E3 ligase and substrates are
complex. Multiple substrates could be targeted by a single
E3 ligase; alternatively, multiple E3 ligases could catalyze
the ubiquitination of a single substrate [9]. These
substrate-enzyme correlations could be used to construct
E3-specific regulatory networks and map to the associated
cellular pathways, making possible the characterization of
complex cellular processes and functional analysis of
E3-sbustrate relationships [9]. This approach has allowed
the discovery of the role that anaphase-promoting complex
(APC)/cyclosome plays in modulating key targets of the cell
cycle, such as cyclins and their related E3 ligases [10–12].
To date, a significant amount of research efforts have
been invested towards the characterization of E3 struc-
tures and examination of the mechanisms underlying
E3-mediated regulatory networks, as well as E3-related
diseases [13–21]. Based on their catalytic mechanisms in
the ubiquitination process, E3 ligases can be classified
into three major types: the HECT (homologous to E6-
AP C-terminus), the RING (really interesting new gene),
and U-box domain types [22]. The HECT-type is re-
sponsible for catalyzing the attachment of ubiquitin to
substrate proteins. In contrast, the RING-type and U-
box-type, similar in both structure and function, facili-
tate the interaction between an E2 enzyme and the tar-
get proteins. Regardless of the types, the significance of
E3-mediated ubiquitination is obvious from their associ-
ation with diseases [23]. Several studies have suggested
that the inhibition of E3 ligases may cause growth
suppression or cell death, as evidenced by the over-
expression of Mdm2/Hdm2, IAPs, and SCF in various
human cancers [24]. Therefore, regulation of E3 ligase
activities and functions may be a promising approach
for cancer treatments.
Many databases and tools have been developed to aid
in the study of E3 ligases. For example, E3Miner [25] of-
fers a text mining approach to identify ubiquitin-protein
ligases, whereas E3Net [9] allows users to search through
a collection of 1671 E3-substrate relationships among 493
E3s and 1277 substrates in 42 organisms. In contrast, by
analyzing protein sequence similarities, domains, and dis-
tributions across different species, Sakiyama et al. [26] con-
structed a useful database for the exploration of proteins
involved in the ubiquitin signaling cascade. Unfortunately,
the present accumulation of large-scale ubiquitinome data
demands for the development of tools that investigate the
regulatory networks of E3 ligases and their substrates.
Here, we present a new strategy that utilizes an interactive
network viewer to assist with the discovery of novel pro-
tein ubiquitination networks. Furthermore, to effectively
investigate the relationships between E3 ligases and their
substrates, metabolic pathways and protein-protein inter-
actions (PPIs) were integrated to construct comprehensive
protein ubiquitination networks. The ability of the
proposed method to identify E3 ligase-mediated ubi-
quitination networks and their biological significance
was demonstrated by case studies. The results indicated
that, despite the current limited knowledge about regula-
tory relationship between E3 ligases and ubiquitinated
proteins, our approach could uncover potential E3 ligase-
substrate relationships based on based on protein-protein
interaction information and substrate site specificities.
Materials and method
Construction of the protein ubiquitination networks in-
volved collection of E3 ligase and ubiquitinated protein
data, integration of ubiquitinated proteins’ functional
data, computational identification of ubiquitination sites
based on substrate motifs, as well as network construc-
tion using protein-protein interactions and metabolic
pathways (Fig. 1). A network viewer was employed to
provide a visualization of the ubiquitination regulatory
network, with implemented functional information, for a
group of proteins of interest. The detailed workflow is
described as follows.
Data collection of E3 ubiquitin ligases and ubiquitinated
proteins
Experimentally validated E1 activating, E2 conjugating,
and E3 ligating enzyme data were obtained from various
sources. From UUCD-Version 1.0 [27], seven distinct E1
activating enzymes were collected. From E3Net, UUCD
[27], hUbiquitome [28], and UniProtKB [29], 494 non-
redundant E3 ubiquitin ligases and their biological
functions were extracted. In addition, a total of 46
non-redundant E2 conjugating enzymes were collected
from UUCD [27], hUbiquitome [28] and UniProtKB
[29]. Experimentally verified ubiquitination sites from
dbPTM [30–32] were also included. Next, search keywords,
such as “ubiquitinated”, “ubiquitination”, “ubiquitylated”, or
“ubiquitylation”, were entered on the PubMed database to
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extract ubiquitinated protein data from research articles.
Specifically, full texts of the matched research articles were
manually reviewed to ensure that the exact ubiquitinated
peptide and modified lysine residue information were
extracted. Finally, redundant data were removed, generating
a total of 41,392 ubiquitinated lysines from 12,786 ubiquiti-
nated human proteins.
Characterization of protein ubiquitination sites
To characterize the amino acid composition of protein
ubiquitination sites, WebLogo [33, 34] was utilized to
generate the relative frequency of the corresponding
amino acid at each position around the ubiquitination sites
as represented by the graphical sequence logo. As well, to
further discriminate the amino acid composition of ubiqui-
tinated sites from their non-ubiquitinated counterparts,
TwoSampleLogo [35] was adopted to display statistically
significant differences in position-specific symbol composi-
tions. The inherent complexity of large-scale ubiquitinome
data may make it difficult to uncover conserved mo-
tifs. To overcome this problem, MDDLogo [36] was
applied to identify potential motifs for the curated
protein ubiquitination sites. MDDLogo is a program that
uses the maximal dependence decomposition (MDD) ap-
proach to discover conserved motifs from groups of
aligned signal sequences through a recursive process that
divides the data sets into tree-like subgroups. The
effectiveness of MDDLogo has been demonstrated in
the identification of substrate motifs for phosphorylation
[37–40], S-nitrosylation [41], O-GlcNAcylation sites [42],
S-glutathionylation [43], as well as ubiquitin conjuga-
tion sites [2].
Data integration for functional investigation of
ubiquitinated proteins
To investigate the biological significance of ubiquitinated
proteins, various biological databases, such as Gene
Ontology (GO) [44], InterPro [45], as well as KEGG Dis-
eases and Pathways [46], were incorporated. To provide
comprehensive functional annotations of proteins associ-
ated with ubiquitination, the ubiquitinated proteins were
classified according to their molecular functions, biological
Fig. 1 System flow of protein ubiquitination network construction
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processes, and cellular components. Since ubiquitination is
known to regulate the cellular localization, interactions,
and degradation of proteins [47–49], the biological roles of
ubiquitination sites within a specific protein domain could
be inferred from the functional annotation of the domain.
For this purpose, essential protein family, domain, and
functional site information was obtained from InterPro
[45], a database which integrates data from various sources
such as the PROSITE [50], PRINTS [51], Pfam [52], and
ProDom [53].
Network construction using protein-protein interactions
and metabolic pathways
Substantial evidence supports the role that protein ubi-
quitination plays in the regulation of cellular processes.
Thus, by integrating experimentally validated mammalian
E3 ubiquitin ligases and their functional information, we
hoped to provide a foundation for navigating ubiquitina-
tion regulatory networks in mammals. To facilitate the
exploration of regulatory relationships between E3 ligases
and their ubiquitinated substrates, associated metabolic
pathways and protein-protein interactions (PPIs) were
included for the comprehensive construction of protein
ubiquitination networks. The human metabolic pathways
were extracted from KEGG [54]. Experimentally veri-
fied PPIs were obtained from over ten PPI databases
(Additional file 1: Table S1). Potential PPIs predicted
based on co-regulation, co-occurrence in the literature,
co-expression, and genomic context were curated from
the STRING database [55]; each interaction included a
confidence score calculated by the STRING built-in
function.
Next, a graph theory [56, 57] approach has been
adopted to illustrate the relationships between E3 ligases
and substrates. Specifically, we use a directed and cyclic
graph G = ( V , E ) to symbolize a protein ubiquitination
network, where x , y ∈ V and ( x , y ) ∈ E. The E3 ligases
and substrate proteins were represented by x and y,
respectively, and protein ubiquitination was denoted
by (x, y) ∈ E to indicate the recognition of a specific
substrate y by E3 ligase x (Additional file 2: Figure S1).
Due to limited knowledge about ubiquitinated substrates
that are recognized by E3 ligases, (x, y) could also repre-
sent a type of protein-protein interaction between E3
ligase x and ubiquitinated protein y. We used V to refer to
all human proteins and E, to all experimentally confirmed
PPIs. Cytoscape [58], a publicly available network viewer,
was employed for the visualization of regulatory networks
among E3 ligases and ubiquitinated substrates.
Results and discussion
Data statistics in this investigation
Data used for building the protein ubiquitination net-
works in this study were experimentally validated and
supported with 39,814 research articles. Over 500 re-
search articles were manually reviewed via a text mining
method. In total, 41,392 ubiquitination sites from 12,786
ubiquitinated proteins in humans were extracted from
406 literatures. After removing redundant data among
heterogeneous online resources, 494 experimentally veri-
fied human E3 ubiquitin ligases remained in the result-
ing data. PPIs between E3 ligases and ubiquitinated
proteins were retrieved to deduce potential regulatory
relationships between E3 ligases and ubiquitinated sub-
strates to compensate for the limited information about
E3 ligase targets. As shown in Table 1, 9,271 physical
PPIs between 426 E3 ligases and 2,649 ubiquitinated
proteins were curated. In particular, by incorporating
the substrate motifs identified by the MDDLogo
ubiquitination site prediction method [36], potential
substrates of E3 ligases could be inferred from the
27,227 PPIs between E3 ligases and other proteins.
Moreover, 377,117 PPIs that appeared to involve ubiquiti-
nated proteins could be integrated for the investiga-
tion of their functional associations in the context of
ubiquitination.
Substrate specificities of human ubiquitination sites
The entropy plots generated by the sequence logo was
used to graphically visualize the amino acid sequences
flanking the substrate sites (at position 0). This allows
for the easy observation of amino acid conservation
surrounding the ubiquitination sites. Figure 2a shows
Leu (L), Glu (E), and Ala (A) to be the most conserved
amino acid residues as indicated by the position-
specific amino aicd composition around the ubiquiti-
nated lysines. Furthermore, using TwoSampleLogo, the
differences in position-specific amino acid composition
between ubiquitinated and non-ubiquitinated sites were
revealed (Fig. 2b). The residues surrounding the ubiqui-
tination sites were significantly enriched with Ala (A),
Asp (D), Glu (E), Leu (L), Gly (G) and Thr (T), and de-
pleted in Cys (C), His (H), Arg (R), Trp (W) and Met
(M) (p < 0.005).
Table 1 Data statistics in this work
Data content Number of records
Ubiquitinated protein (potential E3 substrates) 12,786
Ubiquitination sites 41,392
E3 ubiquitin ligases 494
PPIs between E3 ligases and other proteins 27,227
PPIs between E3 ligases and ubiquitinated proteins 9,271
E3 ligases interacting with ubiquitinated proteins 436
Ubiquitinated proteins interacting with E3 ligases 2,649
Supported articles 39,814
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To overcome the difficulty of discovering conserved
motifs from large-scale ubiquitinome data, the MDDLogo
clustering method was adopted to search for substrate
motifs from the curated human ubiquitination sites using
a 13-mer window length. MDDLogo identified a total of
nine subgroups containing conserved motifs from non-
homologous human ubiquitination sites (Additional file 3:
Table S2). While subgroup 1 (241 ubiquitination sites)
contained the conserved amino acid composition at
positions +3 and +5, the conserved motif of subgroup 2
included Arginine (R), Lysine (K), Phenylalanine (F),
Tyrosine (Y) and Tryptophan (W) residues at position +5.
The conserved motifs of Subgroups 3 and 8 comprised
Glutamic acid (E), Aspartic acid (D), Glutamine (Q) and
Asparagine (N) residues at positions +3 and -2, respect-
ively. In contrast, the remaining subgroups consisted of
Phenylalanine (F), Tyrosine (Y) and Tryptophan (W)
residues at various specific positions in their conserved
motifs. Thus, substrate motifs for ubiquitination sites may
be determined by the position-specific conservation of
Phenylalanine (F), Tyrosine (Y) and Tryptophan (W)
residues. Furthermore, MDDLogo could be utilized to
identify putative ubiquitination sites and potential
interaction between E3 ligase and ubiquitinated pro-
teins based on substrate motif conservation.
Functional associations of E3 ligases and ubiquitinated
proteins
Distributions of GO annotations for E3 ligases and ubiqui-
tinated proteins categorized according to their correspond-
ing biological processes, molecular functions and cellular
components are provided in (Additional file 4: Table S3
and Additional file 5: Table S4), respectively. Following the
InterPro annotation, the most abundant protein domain
for E3 ligases appeared to belong to the “Zinc finger,
RING-type RNA” (Table 2). In a genome-wide study of E3
ligases, it was suggested that the mammalian genomes en-
code more than 600 potential RING finger E3s [59]. E3 li-
gases containing the RING finger domain facilitate the
interaction between an E2 enzyme and a substrate to medi-
ate the transfer of ubiquitin from E2 to the target [60, 61].
On the other hand, those with the HECT domain are in-
volved in the regulation of cellular trafficking, immune re-
sponse, cellular growth and proliferation [62]. The HECT
domain containing E3 ligases form a catalytic intermediate
with ubiquitin and is responsible for the catalysis of two re-
actions: 1) transesterification reaction, in which ubiquitin
from the cysteine residue at the E2 active site is transferred
to another cysteine residue in the HECT domain [60]; 2)
the subsequent attack of a substrate lysine on the thioester
of the ubiquitin-bound HECT domain [63] (Additional file
Fig. 2 Amino acid composition of protein ubiquitination sites. a The frequency plot of ubiquitinated sites. b The compositional biases of amino
acids around ubiquitination sites compared to the non-ubiquitination sites
Huang et al. BMC Systems Biology 2016, 10(Suppl 1):3 Page 31 of 119
6: Figure S2). Whereas the C-terminus of the HECT do-
main is more conserved, the N-terminus, the part that me-
diates substrate targeting, is more diverse [62].
According to the annotation information on InterPro,
approximately 70 % of established ubiquitination sites
are mapped to specific functional domains, suggesting
that ubiquitination may modulate a variety of bio-
logical functions. The top 50 InterPro functional do-
mains containing ubiquitinated sites in humans are
given in Table 3. It appeared that most ubiquitination
sites could be found in the MHC class I (alpha chain)
protein domains. It has been reported that viral proteins
could induce the degradation of the histocompatibility
complex (MHC) class I protein in the endoplasmic
reticulum and at the cell surface by ubiquitinating the
MHC class I domain [64]. The immunoglobulin C1-
set domain, or classical Ig-like domains that resemble
the antibody constant domain, is another domain found
to be enriched with ubiquitinated sites. Interestingly,
these domains were found exclusively in mediators of
immune response, including various T-cell receptors,
MHC class I and II complexes [65].
Network analysis for a group of interested proteins
To allow users to efficiently search for the proteins of
their interest, a convenient interactive network viewer
was implemented in the proposed method implemented
an interactive network viewer. An example of construct-
ing a protein ubiquitination network using our approach
is illustrated in (Additional file 7: Figure S3). The net-
work was built with four E3 ligases, 14 ubiquitinated
proteins and three other proteins. While the established
interactions between the four E3 ligases and 14 ubiquiti-
nated proteins were immediately recognized, three other
proteins interacting with two of the E3 ligases were also
revealed as potential ubiquitinated substrates. For in-
stance, E3 ligase MDM2 was predicted to target Fork-
head box protein O3 (FOXO3) for ubiquitination. This
is consistent with a recent study supporting MDM2 to
be an E3 ligase responsible for the ubiquitin-mediated
degradation of FOXO3 [66]. As well, our approach
could provide the potential ubiquitination sites and
the corresponding substrate motifs for a specific
protein. Furthermore, for a specific E3 ligase and
their interacting ubiquitinated proteins, the analysis
could even be extended to exploring their functional
associations and creating a comprehensive ubiquitin
regulatory network.
A case study of the discovered E3 ligases associated with
the regulation of p53
In cases where information is limited with respect to the
interaction between an E3 ligase and its corresponding
substrates, our strategy could still identify the potential
Table 2 The distribution of top 20 functional domains for human E3 ligases
No. InterPro ID Domain terms Number of proteins % Total
1 IPR001680 WD40 repeat 287 57.5150 %
2 IPR006652 Kelch repeat type 1 68 13.6273 %
3 IPR000408 Regulator of chromosome condensation, RCC1 55 11.0220 %
4 IPR001841 Zinc finger, RING-type 54 10.8216 %
5 IPR000315 Zinc finger, B-box 48 9.6192 %
6 IPR003877 SPla/RYanodine receptor SPRY 38 7.6152 %
7 IPR013069 BTB/POZ 28 5.6112 %
8 IPR000569 HECT 28 5.6112 %
9 IPR001202 WW/Rsp5/WWP 28 5.6112 %
10 IPR020683 Ankyrin repeat-containing domain 27 5.4108 %
11 IPR001496 SOCS protein, C-terminal 25 5.0100 %
12 IPR002867 Zinc finger, C6HC-type 23 4.6092 %
13 IPR018957 Zinc finger, C3HC4 RING-type 22 4.4088 %
14 IPR001258 NHL repeat 21 4.2084 %
15 IPR011705 BTB/Kelch-associated 15 3.0060 %
16 IPR002110 Ankyrin repeat 14 2.8056 %
17 IPR000571 Zinc finger, CCCH-type 11 2.2044 %
18 IPR001876 Zinc finger, RanBP2-type 11 2.2044 %
19 IPR011016 Zinc finger, RING-CH-type 11 2.2044 %
20 IPR001452 Src homology-3 domain 10 2.0040 %
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Table 3 Distribution of the top 50 functional domains covering ubiquitination sites
No. Domain (InterPro) ID Domain (InterPro) terms Number of sites % Total
1 IPR001039 MHC class I, alpha chain, alpha1/alpha2 1625 3.6574 %
2 IPR003597 Immunoglobulin C1-set 1321 2.9732 %
3 IPR001680 WD40 repeat 1043 2.3475 %
4 IPR002017 Spectrin repeat 1012 2.2777 %
5 IPR010579 MHC class I, alpha chain, C-terminal 729 1.6408 %
6 IPR003961 Fibronectin, type III 469 1.0556 %
7 IPR000504 RNA recognition motif domain 419 0.9431 %
8 IPR000719 Protein kinase, catalytic domain 338 0.7607 %
9 IPR013098 Immunoglobulin I-set 232 0.5222 %
10 IPR020683 Ankyrin repeat-containing domain 230 0.5177 %
11 IPR017868 Filamin/ABP280 repeat-like 212 0.4772 %
12 IPR006209 EGF-like domain 179 0.4029 %
13 IPR001715 Calponin homology domain 177 0.3984 %
14 IPR010630 Neuroblastoma breakpoint family (NBPF) domain 168 0.3781 %
15 IPR001452 Src homology-3 domain 167 0.3759 %
16 IPR006652 Kelch repeat type 1 158 0.3556 %
17 IPR000408 Regulator of chromosome condensation, RCC1 157 0.3534 %
18 IPR000225 Armadillo 156 0.3511 %
19 IPR004088 K Homology domain, type 1 154 0.3466 %
20 IPR001650 Helicase, C-terminal 146 0.3286 %
21 IPR002126 Cadherin 145 0.3264 %
22 IPR000048 IQ motif, EF-hand binding site 143 0.3219 %
23 IPR000083 Fibronectin, type I 143 0.3219 %
24 IPR000626 Ubiquitin 142 0.3196 %
25 IPR000008 C2 calcium-dependent membrane targeting 135 0.3038 %
26 IPR001806 Small GTPase superfamily 125 0.2813 %
27 IPR001245 Serine-threonine/tyrosine-protein kinase catalytic domain 125 0.2813 %
28 IPR000433 Zinc finger, ZZ-type 123 0.2768 %
29 IPR001478 PDZ domain 122 0.2746 %
30 IPR001849 Pleckstrin homology domain 120 0.2701 %
31 IPR011545 DNA/RNA helicase, DEAD/DEAH box type, N-terminal 112 0.2521 %
32 IPR019787 Zinc finger, PHD-finger 111 0.2498 %
33 IPR001440 Tetratricopeptide TPR-1 111 0.2498 %
34 IPR001202 WW/Rsp5/WWP 110 0.2476 %
35 IPR018108 Mitochondrial substrate/solute carrier 110 0.2476 %
36 IPR001781 Zinc finger, LIM-type 106 0.2386 %
37 IPR001101 Plectin repeat 104 0.2341 %
38 IPR002049 EGF-like, laminin 100 0.2251 %
39 IPR002429 Cytochrome c oxidase subunit II C-terminal 96 0.2161 %
40 IPR011759 Cytochrome C oxidase subunit II, transmembrane domain 96 0.2161 %
41 IPR003439 ABC transporter-like 91 0.2048 %
42 IPR001487 Bromodomain 91 0.2048 %
43 IPR018502 Annexin repeat 88 0.1981 %
44 IPR000980 SH2 domain 86 0.1936 %
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E3 ligases that may target a specific ubiquitinated pro-
tein. A case study is shown in Fig. 3, demonstrating the
ability of the proposed method to construct an inter-
action map for the ubiquitination of tumor suppressor
p53 (TP53). The resulting network is consistent with the
literature. As a transcription factor, the tumor suppres-
sor protein p53 responds to stress such as DNA damage
by inducing cell cycle arrest and apoptosis [67]. Recent
evidence has established that MDM2, a RING oncopro-
tein and a negative regulator of p53 [24], modulates the
proteasomal degradation of p53 via a RING-finger-
dependent manner [68–72]. Yet, our approach
discovered other E3 ligases that may also regulate
the ubiquitination of p53. Thus, the proposed strat-
egy has the ability to uncover potential substrates
for a specific E3 ligase, as well as potential E3 li-
gases for ubiquitinated proteins.
Conclusion
In an attempt to characterize the regulatory role protein
ubiquitination plays in a variety of biological processes,
we combined the information of E3 ligases, ubiquiti-
nated proteins, and protein-protein interactions to con-
struct a comprehensive network of E3 ligases and their
Table 3 Distribution of the top 50 functional domains covering ubiquitination sites (Continued)
45 IPR003008 Tubulin/FtsZ, GTPase domain 77 0.1733 %
46 IPR001421 ATPase, F0 complex, subunit 8, mitochondrial, Metazoan 75 0.1688 %
47 IPR013069 BTB/POZ 75 0.1688 %
48 IPR003959 ATPase, AAA-type, core 74 0.1666 %
49 IPR007087 Zinc finger, C2H2 74 0.1666 %
50 IPR000197 Zinc finger, TAZ-type 74 0.1666 %
Fig. 3 A case study of the discovered E3 ligases associated with the regulation of tumor suppressor p53 (TP53)
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ubiquitinated substrates. Designed to serve as not only a
meaningful platform for investigating E3-substrate regula-
tory networks but also a new strategy to uncover potential
E3 ligases for ubiquitinated substrates, the proposed ap-
proach allows for the efficient characterization of protein
ubiquitination networks from large-scale ubiquitinome
data. With access to more updated data, the proposed
scheme can be further refined for the study of E1 activat-
ing enzymes, E2 conjugating enzymes, and E3 ubiquitin
ligases. Also, recent publications regarding the structural
environment of experimentally validated ubiquitination
sites based on protein tertiary structures [73–76] could be
incorporated to infer the functional interactions between
the enzymes and substrates. Finally, confirmed functional
annotations of ubiquitination sites could be extracted
from the literature via a more advanced information
retrieval system to collect more adequate information
required for further functional analyses.
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